<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">Among all Stratum 2 subjects, the two-year EFS was 51% ± 8% and OS was 84% ± 6% (Fig. 
 <xref rid="Fig3" ref-type="fig">3a,b</xref>) with a median follow-up time of 3.7 years (range 2.1–5.8 years). Previously relapsed subjects (N = 18) had an EFS of 35% ± 11% and OS of 80% ± 9% at two years (Fig. 
 <xref rid="Fig3" ref-type="fig">3c/d</xref>). Subjects with primary refractory disease (N = 21) had an EFS of 68% ± 11% and OS of 89% ± 7% at two years (Fig. 
 <xref rid="Fig3" ref-type="fig">3e/f</xref>).
</p>
